By: ICN Bureau
Last updated : November 06, 2025 9:26 pm
During the quarter, the company's sales dropped by 16.3 per cent to €1.34 billion as compared to €1.60 billion in Q3 2024
Lanxess has reported a decline in sales and net income in the third quarter of 2025 due to the weak economic environment and geopolitical uncertainties. The company also specified its full-year 2025 earnings guidance to the lower end of its previous forecast.
During the quarter, the company's sales dropped by 16.3 per cent to €1.34 billion as compared to €1.60 billion in Q3 2024. EBITDA pre exceptionals also fell by 27.7 per cent to €125 million, compared with the prior-year figure of €173 million.
The company reported a net loss of €77 million, a significant decrease from a €1 million profit in Q3 2024.
This decline was primarily due to generally weak demand, which led to lower sales volumes. In addition, the sale of the Urethane Systems business unit on April 1, 2025 – whose results are no longer included in the quarterly figures – and adverse currency effects also contributed to the decline in the Group’s earnings.
The EBITDA margin pre exceptionals for the third quarter was 9.3 percent, compared with 10.8 percent in the same period last year.
“The ongoing weakness in global demand continues to impact the entire chemical industry, including us. The situation is particularly dramatic in our target industries of construction, automotive and agrochemicals. We currently see no light at the end of the tunnel and expect this situation to continue well into next year,” said Matthias Zachert, CEO, Lanxess.
“We are therefore continuing to focus all our energy on what we can influence: reducing costs, streamlining processes and structures, and optimizing our market positioning.” Nevertheless, the chemical industry needs further support from politicians. Zachert said: “Berlin and Brussels must strengthen our competitiveness much more quickly and decisively – otherwise entire value chains are at risk.”
Lanxess has specified its guidance for the full year 2025 and now expects EBITDA pre exceptionals to be around the lower end of the range of €520 to €580 million.
Lanxess is implementing further cost-reduction measures worth around €100 million in additional annual savings by the end of 2027, building on its existing "FORWARD!" action plan.